Table 4.
Landmark Survival Analysis on Survival Time From ICU Admission to Death.
| Hazard Ratio (95% CI) | P Value | |
|---|---|---|
| 2-day landmark analysis using RRT and no RRT groups | ||
| RRT vs No | 1.153 (0.882-1.506) | .2979 |
| Age at admit | 1.000 (0.992-1.007) | .9389 |
| Baseline serum albumin level | 0.781 (0.665-0.916) | .0024 |
| Baseline creatinine level | 1.014 (0.967-1.064) | .5585 |
| Baseline eGFR value | 0.998 (0.994-1.001) | .2493 |
| Baseline Max SOFA | 1.053 (1.030-1.076) | <.000l |
| 2-day landmark analysis using propensity score-matched cohorts | ||
| RRT vs No | 1.211 (0.879-1.669) | .24l3 |
| Age at admit | 0.998 (0.987-1.009) | .6925 |
| Baseline serum albumin level | 0.775 (0.598-1.004) | .0536 |
| Baseline creatinine level | 1.024 (0.955-1.099) | .5053 |
| Baseline eGFR value | 1.001 (0.993-1.009) | .8497 |
| Baseline Max SOFA | 1.058 (1.0l5-1.103) | .0082 |
| 7-day landmark analysis using RRT and no RRT groups | ||
| RRT vs No | 0.911 (0.660-1.256) | .5678 |
| Age at admit | 1.001 (0.993-1.010) | .8l43 |
| Baseline serum albumin level | 0.805 (0.666-0.974) | .0256 |
| Baseline creatinine level | 1.032 (0.982-1.085) | .2l28 |
| Baseline eGFR value | 1.001 (0.997-1.004) | .7290 |
| Baseline Max SOFA | 1.043 (1.0l3-1.073) | .0046 |
| 7-day landmark analysis using propensity score-matched cohorts | ||
| RRT vs No | 0.917 (0.620-1.356) | .6636 |
| Age at admit | 1.005 (0.99l-1.019) | .4620 |
| Baseline serum albumin level | 0.797 (0.594-1.068) | .1283 |
| Baseline creatinine level | 1.028 (0.928-1.139) | .5966 |
| Baseline eGFR value | 0.999 (0.990-1.008) | .8380 |
| Baseline Max SOFA | 1.054 (0.997-1.115) | .0650 |
Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; ICU, intensive care unit; RRT, renal replacement therapy; SOFA, Sequential Organ Failure Assessment.